AXIL Fiscal Q1 2027 Earnings: XCOR II Transition Weighs on Revenue

AXIL Brands (NYSE American: AXIL) reported fiscal Q1 2027 net revenue of $6.09 million, down 11.2% from $6.86 million a year earlier, while diluted EPS rose to $0.05 from $0.04. For the quarter ended August 31, 2026, the transition from XCOR to XCOR II and a non-repeating big-box order reduced sales, but a non-recurring customs-duty refund supported profitability and receivables collection drove a sharp improvement in operating cash flow. Initial XCOR II orders exceeded $3.6 million by September 30, with shipments underway in fiscal Q2.

Core Earnings Data

Revenue declined as AXIL managed the planned slowdown of first-generation XCOR sales ahead of XCOR II availability. The prior-year comparison also included a material big-box order that did not recur, while direct-to-consumer revenue in the hearing business fell by less than 1%.

Reported gross profit increased despite lower revenue, primarily because cost of revenue included a $0.55 million customs-duty refund. Operating expenses rose to $4.59 million from $4.22 million, but operating income still increased modestly.

Adjusted EBITDA is a non-GAAP measure that excludes taxes, net interest, depreciation and amortization, and stock-based compensation.

Business and Product Performance

The XCOR II launch was the quarter’s main operational development, but its revenue contribution fell outside fiscal Q1. AXIL announced the product on August 26 and began availability on September 15. Initial orders exceeded $2.8 million by August 26 and $3.6 million by September 30 across retail, distribution, and direct-to-consumer channels.

Fiscal Q1 included approximately $360,000 of advertising costs and inventory staging for the launch without a corresponding revenue benefit. Shipments began in fiscal Q2, and management said most of the XCOR II backlog had been fulfilled by September 30.

AXIL also brought three strategic partners into Reviv3 ProCare to lead the planned global relaunch of its hair and skin care brand. The partners received an aggregate ownership interest of approximately 25% in exchange for services. AXIL retained approximately 75%, continues to consolidate Reviv3’s results, and recorded a $137,511 non-cash expense for the shares issued.

One-Time Duty Refund Lifted Margins While Launch Costs Preceded Revenue

AXIL’s 82.6% reported gross margin was materially affected by a non-recurring customs-duty refund. Excluding the $0.55 million reduction in cost of revenue, gross margin would have been approximately 73.6%, compared with 67.6% in the prior-year quarter. The company’s adjusted EBITDA reconciliation does not remove the refund, so adjusted EBITDA also retains that benefit.

AXIL received approximately $0.9 million in total refunds and interest. In addition to the amount recognized in cost of revenue, $0.32 million reduced the carrying value of inventory and $0.04 million was recorded as interest income. No related refund claims remain outstanding, making the reported margin level an unsuitable baseline for subsequent quarters.

At the same time, total operating expenses increased by approximately $372,000. Research and development expense was $459,631 versus none in the prior-year quarter, and the period included XCOR II advertising costs and the Reviv3 non-cash expense. These costs arrived before the related product launch generated fiscal Q1 revenue.

Cash Flow and Balance Sheet

Operating cash flow swung to a $3.76 million inflow from a $739,000 outflow a year earlier. The largest contributor was a $3.45 million cash-flow benefit from the change in accounts receivable. Accounts receivable declined to $1.33 million at August 31 from $4.75 million at May 31.

Cash increased by $3.47 million during the quarter to $7.93 million. AXIL reported no outstanding borrowings, while inventory remained nearly unchanged at $4.44 million compared with $4.42 million at the end of the preceding fiscal year. The inventory balance included the $0.32 million reduction associated with the customs-duty refund.

Risks Investors Should Monitor

• XCOR II order conversion: Initial demand was measured in orders rather than recognized fiscal Q1 revenue. The timing and value of future revenue depend on shipments, cancellations, and returns.
• Gross-margin normalization: The $0.55 million customs-duty benefit was non-recurring, and AXIL has no remaining refund claims. Future reported margins will not receive the same support.
• Customer and order concentration: The absence of a material big-box order that occurred in the prior-year quarter contributed to the revenue decline, illustrating the potential effect of individual large orders.
• Costs arriving ahead of sales: Advertising, product-development spending, and launch preparation increased expenses before XCOR II contributed revenue. Delays in sales conversion could therefore pressure operating profitability.

Summary

AXIL’s fiscal Q1 2027 was a product-transition quarter: revenue declined as first-generation XCOR sales slowed and a prior-year large order did not repeat, while XCOR II revenue had not yet begun. Reported earnings improved with help from a one-time duty refund, and cash generation strengthened primarily through receivables collection. The next key points are the conversion of XCOR II orders into revenue, underlying margins after the refund benefit, and whether launch-related spending produces sustained sales growth.